Analysts are upbeat about the potential for IBM’s software business, despite disappointing performance there in the most ...

Wedbush analyst maintains Outperform rating and $325 price forecast for IBM. Strong fiscal Q2 results and reaffirmed ...

International Business Machines ($IBM) is set to report its second-quarter earnings on July 23 after the market closes. Wall ...

Coming into the report, IBM stock had an IBD Composite Rating of 83 out a best possible 99, according to IBD Stock Checkup.

The heavy selling pressure might have exhausted for IBM (IBM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in ...

IBM shares sank Thursday, as slightly weaker-than-expected software revenue growth is weighing on a second-quarter earnings ...

Analysts are estimating that IBM will report an earnings per share (EPS) of $2.65. IBM bulls will hope to hear the company ...

IBM stock gets slammed after reporting positive Q2 result. Revenue beat forecasts by $385 million as infrastructure revenue rose 14% YoY. Analysts largely take positive view of IBM despite market sell ...

IBM's Q2 risks include government spending cuts, tariffs, and consulting pullbacks. Read more on IBM's AI-driven growth, ...

International Business Machines Corporation (NYSE:IBM) is one of the AI Stocks on Analysts’ Radar Right Now. On July 21, BofA ...

IBM's Q2 results actually beat Wall Street's expectations, but investors are seeing worrying signs in the report.

Last week, an analyst at Wedbush boosted his price target on IBM stock from $300 to $325, implying an additional 16% upside from Friday's closing price. While analyst price targets shouldn't carry ...